ML · Devices · Protein and materials design · Electrogenetics · Bio-interfaces

Ariel J.
Ben-Sasson

Founder and CEO, molCore

I build the layer of biology that evolution could not, and that modern engineering needs: molecules and materials that are biological and synthetic at once. Bottom-up function at biology's precision, top-down scale and durability at technology's reach. That dual nature is what a brain-computer interface at biology's own resolution will take, and reaching it is the long-term objective, the compass behind everything I build.

Behind: transmission electron micrograph of a designed binary protein array.

Portrait of Ariel J. Ben-Sasson

In a nutshell

Founder and CEO of molCore. I am an engineer who built the first vertical organic field-effect transistors at the Technion and the first binary macro-scale protein materials in the Baker Lab. I am driven by the vision of molecular-resolution brain-computer interfaces.

Scientist-in-residence at Abiologics, and on the scientific advisory board of Decycle Bio. Formerly co-founder and CTO of ZipBio, and a Baker Lab scientist.

Current focus

  • Asset-driven drug development company building a proprietary platform to generate resilient biologics and biomaterials through a fundamentally new approach to protein engineering.
  • Methods to create proteins and protein materials that biology has not, or could not, create.
  • Protein materials and electrogenetics.
  • My interactive publications ↗

How I work

Rare in nature, unusable as found. The principle, engineered, scales.

Sketch: a person observes a rare natural phenomenon, imagines an abstracted principle, and a city is built from it

There are natural phenomena which are rare, almost invisible, and unusable in their native form. The principles behind them, coupled with engineering, unlock transformative function at scale.

The gap between biology and hardware

Biology signals with ions and molecules through soft, dynamic, self-built matter, in which hardware and software are entangled and barely understood. Silicon operates with electrons through rigid inorganic matter: scalable, resilient, and fixed in architecture once it leaves the fab. Something has to cross between them, and today, invasive or not, the crossing is far from ideal.

Microelectrode arrays read a blur of many neurons at once, and the tissue reacts to them. Optogenetics and sonogenetics are genetically encoded, but even at their best they resolve a single neuron, still far coarser than the computation going on inside one. Against what a cortex actually does, the resolution on offer, even with wishful thinking, is a 16-pixel screen against an 8K film, and the bandwidth is as lopsided as pre-fiber cable internet, fast in one direction and a trickle in the other.

Through my career I have been building the foundational stack for biology's upper-limit BCIs: interfaces that operate at the resolution of a single molecule, a single synapse, the way neurons interact with neurons, and that borrow the properties of both biology and modern hardware. Protein materials, so the interface can be built bottom up by cells and manufactured top down, to transduce an ionic signal into an electron event, cross the membrane, conduct over long range, and persist under biological and synthetic conditions alike. Electrogenetics, so a cell grows its own contact instead of having one implanted. And persistent biologics, so what is built holds up for years, in a body and at the interface and scale of modern hardware. Each field I worked in added one piece.

ML and neural networks
2002–2006 · Technion · when we still called them liquid state machines

Majored in imaging and digital signal processing. Developed a rational framework for multilayer perceptrons as a final project; the work contributed to the spinout of Cortica, an early autonomous AI venture.

TechnionCortica
Making electronics soft and self-assembling
2006–2013 · Technion · PhD, Nanoscience and Nanotechnology

Pioneered the vertical organic field-effect transistor: its operating physics, its fabrication methods, and the first self-assembling implementation, patterning the source electrode across centimetre scales.

Technion
Schematic of a vertical organic field-effect transistor

The source electrode, patterned by block-copolymer self-assembly, across centimetres.

Building matter from sequence
2013–2021 · Institute for Protein Design · Baker Lab

Pioneered the first de novo designed binary protein 2D materials, showing that two computationally designed components can co-assemble into geometrically defined, biologically active lattices, then co-led a six-year effort using designed assemblies to direct cell fate.

University of WashingtonInstitute for Protein DesignNobel Prize medal
Designed two-component protein lattice: the design, the rendered lattice, and the observed lattice, with symmetry markers

Designed binary honeycomb lattice, two components, atomic precision. Nature, 2021.

From designed proteins to drugs
2022–2025 · ZipBio · co-founder and CTO

Co-founded, and served as CTO of, a drug discovery company built on de novo protein design. I built the team, and with it the platform and the assets. We showed that de novo binder design could reach a 75% success rate as early as 2023, and that in some cases early development can be compressed to under six months, from a program's inception to positive animal-model validation.

ZipBio
Mirror biology and enzyme design
2025– · Abiologics · Decycle Bio

Scientist-in-residence, directing the computational biology drug discovery team at Abiologics, a Flagship Pioneering company advancing mirror-biology therapeutics. Scientific advisor at Decycle Bio on machine learning for de novo enzyme design.

AbiologicsFlagship PioneeringDecycle Bio
The persistence layer
2026– · molCore · founder and CEO

Asset-driven drug discovery company, engineering the fragility out of proteins while keeping their function. We build the technology and the molecular platform for next-generation biologics, and the foundation for persistent biomaterials.

molCore
Biology's upper-limit BCI
RealTime-Biology · electrogenetics

Genetically encoded, electron-conductive protein materials that let neurons and silicon speak in the same currency, in both directions, at single-axon resolution. Every stage above is a piece of it.

RealTime-Biology mark: a designed protein helix at the centre of a neuron, with circuit traces extending from it
molCore landing page ↗

Statement 2025 · research proposal 2013, supported by HFSP

RealTime-Biology

The 2013 research proposal behind it, Design and study of electrically-conductive de novo protein assemblies, won a Human Frontier Science Program fellowship and took me to the Baker Lab to build the platform materials electrogenetics runs on.

“What if we could build something that would allow silicon to interface with neurons at the same complexity and resolution neurons interface with each other?”
Read the transcript, PDF Ariel J. Ben-Sasson · December 2025
RealTime-Biology mark: a designed protein helix at the centre of a neuron, with circuit traces extending from it
Electrogenetics: the neuron, the designed conductive protein, and the circuit as one continuous path.

The neuron, the designed protein, and the circuit as one continuous path.

Visualization, flying, and running

I like making scientific visualizations, and I liked it even back when it was genuinely hard: PyMOL, Python and Blender, a frame at a time, in the era before you could just ask a model. A few results, overnight renders and all, are on a YouTube channel. Helicopter pilot and general aviation. Trail running and orienteering, which is mostly the same skill as research: move fast, stay found. English, Hebrew, and French.

P.S. The avatar on my GitHub profile is my name, folded as a protein sequence.

Academic lab

Programmable protein materials and electrogenetics

TBD